Heska Corporation Revenue and Competitors
Estimated Revenue & Valuation
- Heska Corporation's estimated annual revenue is currently $300M per year.
- Heska Corporation received $30.0M in venture funding in July 2017.
- Heska Corporation's estimated revenue per employee is $797,872
- Heska Corporation's total funding is $178.6M.
Employee Data
- Heska Corporation has 376 Employees.
- Heska Corporation grew their employee count by 1% last year.
Heska Corporation's People
Name | Title | Email/Phone |
---|---|---|
1 | VP | Reveal Email/Phone |
2 | EVP | Reveal Email/Phone |
3 | VP, Global Finance & Treasury | Reveal Email/Phone |
4 | VP Marketing | Reveal Email/Phone |
5 | EVP & CFO | Reveal Email/Phone |
6 | VP Customer Care | Reveal Email/Phone |
7 | VP, Operations | Reveal Email/Phone |
8 | VP, Global Tax | Reveal Email/Phone |
9 | EVP & COO | Reveal Email/Phone |
10 | EVP, Corporate Development | Reveal Email/Phone |
Heska Corporation Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $3.5M | 42 | -5% | N/A | N/A |
#2 | $300M | 376 | 1% | $178.6M | N/A |
#3 | N/A | 22 | 29% | N/A | N/A |
#4 | N/A | 4 | 0% | N/A | N/A |
#5 | N/A | 26 | 13% | N/A | N/A |
#6 | N/A | 4 | -86% | N/A | N/A |
#7 | $75M | 699 | -1% | N/A | N/A |
#8 | $1.7M | 23 | -28% | N/A | N/A |
#9 | $15M | 422 | 31% | N/A | N/A |
#10 | N/A | 24 | -14% | N/A | N/A |
What Is Heska Corporation?
Heska is dedicated to quality pet care. Through innovation, invention, and strategic partnerships with worldwide leaders in diagnostics and treatments, Heska provides the benefits of latest generation technologies to pet healthcare providers. Heska's range of complete blood diagnostic solutions include Chemistry, Hematology, Blood Gas & Electrolytes, Immunodiagnostics, Heartworm, and other blood testing. Treatments and testing include Immunotherapy and complete Allergy solutions. Heska's digital imaging lineup boasts the latest High Definition Digital Radiography and Digital Ultrasound technologies, paired with Cloud Based data archival, management, and sharing services. Because veterinarians and pet owners work hard for every dollar, Heska is dedicated to providing products with superior outcomes at better value pricing. Since diagnostics is first in the chain of healthcare services, Heska believes that by providing superior accuracy, speed, and cost, pet owners can save more dollars, which they can then invest in treatment and ongoing pet healthcare after diagnosis. Heska is dedicated to the idea that diagnostics can be provided more accurately and more affordably, allowing veterinarians to invest those hard earned and saved dollars back into their patients, staff, and hospitals. For this reason, Heska created Reset a program that provides accurate, better and faster blood testing at 40% less cost than with other competitive in-house lab solutions. REAL customers are experiencing REAL savings, using equipment they love with results they can trust. That's the Heska way.
keywords:Biotechnology,E-Commerce,Healthcare,Medical Diagnostics,Pharmaceuticals$178.6M
Total Funding
376
Number of Employees
$300M
Revenue (est)
1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Heska Corporation News
LOVELAND, Colo., April 18, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of...
Institutional investors and hedge funds own 94.47% of the company's stock. About Heska (Get Rating). Heska Corporation sells veterinary and...
Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $102.1M | 389 | -8% | N/A |
#2 | $87.8M | 467 | 10% | N/A |
#3 | $198.7M | 548 | 4% | N/A |
#4 | $35M | 556 | 8% | N/A |
#5 | $129.2M | 594 | -6% | N/A |
Heska Corporation Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2017-07-28 | $30.0M | Undisclosed | JPMorgan Chase | Article |